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ABSTRACT: The ongoing research to improve the clinical
outcome of titanium implants has resulted in the implemetation
of multiple approches to deliver osteogenic growth factors
accelerating and sustaining osseointegration. Here we show the
presentation of human bone morphogenetic protein 7 (BMP-7)
adsorbed to titanium discs coated with poly(ethyl acrylate)
(PEA). We have previously shown that PEA promotes
ﬁbronectin organization into nanonetworks exposing integrin-
and growth-factor-binding domains, allowing a synergistic
interaction at the integrin/growth factor receptor level. Here, titanium discs were coated with PEA and ﬁbronectin and then
decorated with ng/mL doses of BMP-7. Human mesenchymal stem cells were used to investigate cellular responses on these
functionalized microenvironments. Cell adhesion, proliferation, and mineralization, as well as osteogenic markers expression
(osteopontin and osteocalcin) revealed the ability of the system to be more potent in osteodiﬀerentiation of the mesenchymal
cells than combinations of titanium and BMP-7 in absence of PEA coatings. This work represents a novel strategy to improve the
biological activity of titanium implants with BMP-7.
KEYWORDS: bone morphogenetic protein 7, ﬁbronectin network, osteogenic diﬀerentiation, poly(ethyl acrylate) (PEA),
functionalized titanium
1. INTRODUCTION
Bone-healing properties of demineralized bone have been
known since the end of 19th century; however, it was not until
the 1960s when a seminal paper was published describing the
osteoinductive eﬀect of bone morphogenetic proteins
(BMPs).1,2 Titanium (Ti) provides a high strength and a low
elastic modulus, reducing the impact of peri-implant bone
resorption. Ti chemistry favors the formation of a biocompat-
ible titanium oxide surface layer, which also imparts increased
resistance to corrosion. Therefore, Ti is often regarded as a
more advantageous implant material, when compared with
other metals such as cobalt, nickel, chromium, and their
respective alloys.3,4 The rate of bone formation, the implant
surface area directly contacting bone, and the mechanical
properties of the bone/implant interface are inﬂuenced by the
nature of the implant surface.5 Previous studies to enhance the
surface of Ti as an implant material were challenged by
confounding factors.4 These included physical characteristics
(e.g., surface roughness) and multiple biologically active factors
in the serum when the samples were tested in vitro.4,6
One option to enhance the biocompatibility of artiﬁcial
implants is the deposition of extracellular matrix (ECM)
proteins onto these surfaces with the purpose to mediate cell−
matrix adhesion. Among others, ﬁbronectin (FN) is one of the
soluble ECM proteins playing a critical role in osteogenic
diﬀerentiation.4,7−9 It was also found that crucial binding sites
for many growth factors on the FN molecule become available
when FN is unfolded. It is important to note that these sites are
not available when the FN is in its globular conformation.7,10
In previous works, we have shown that adsorption of FN
onto poly(ethyl acrylate) (PEA) induced unfolding and then
spontaneous organization into nanonetworks, enhancing the
availability of both integrin binding domain (FNIII9−10) and
the growth factor binding regions (FNIII12−14).7,10 The
signiﬁcance of the synergistic eﬀect of integrin and growth
factor receptor signaling on PEA/FN substrate has already been
reported for the BMP-2-functionalized system, which enhanced
osteogenic diﬀerentiation of hMSC in vitro.11 Moreover,
speciﬁc VEGF binding to FNIII12−14 on PEA stimulated
endothelial cells toward vessel formation.12
Bone morphogenetic proteins (BMPs) act as potent
regulators during bone and cartilage formation and repair,
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mainly through the SMAD pathway.8,13 The ability to achieve
an early localized continuous expression of BMPs around
implants has been the focus of many previous studies.14
Recombinant human BMP-2 and BMP-7 have been approved
for clinical use in the regeneration of bone for fracture healing
and spinal fusion.2 Even though BMP-2 has gained much of the
focus in the previous literature for bone regeneration,2 recent
studies have demonstrated the potential of BMP-7 as bone
regeneration stimulator.8,15 Besides, it has been documented
that BMP-7 induces the commitment of undiﬀerentiated
nonosteogenic cells into osteoblasts as well as stimulating the
maturation of committed osteoblast progenitors.8 Finally,
BMP-7 has also demonstrated promising bone regenerative
capacity in vivo.16
Regarding the clinical use of these growth factors (GF), GFs
are usually administered by being released from a scaﬀold or
sponge, and it has been shown they can provide signiﬁcant
osseoinductive signals.2 However, the therapy is often linked
with side eﬀects that are mostly related to the high dosage
necessary because of relatively high degradation rate
(proteolysis) and fast clearance (due to the initial inﬂammatory
response).2,14,17 This demonstrates the need for a more reliable
delivery system to ensure adequate protein concentration at the
target sites.2,14,18
Our approach involves the adsorption of BMP-7 onto
titanium surfaces coated with PEA and FN (organized into
nanonetworks). This conﬁguration allowed us to dramatically
decrease the doses of BMP-7 used to stimulate functionaliza-
tion of artiﬁcial implants, while keeping its osteogenic
capabilities (Figure 1a). The target outcome would be a
better/faster local response of hMSCs toward osteoblastic
diﬀerentiation on this surface.
2. MATERIALS AND METHODS
2.1. Titanium Discs and Polymer Coating. Titanium discs were
fabricated from Ti metal (99.995% purity, Pi-KEM Ltd.) deposited on
12 mm diameter glass coverslips using a Plassys MEB550S Electron
Beam Evaporator (Kelvin Nanotechnology Ltd.). To reach a thickness
of 750 nm of Ti, the deposition rate was 0.3 nm/s. Poly(ethyl acrylate)
(PEA) was synthesized and spin-coated onto the titanium discs
following the protocol described by Vanterpool et al.7 Brieﬂy, PEA
sheets were prepared by radical polymerization of ethyl acrylate
solutions using 1% benzoin as photoinitiator. Thin ﬁlms were prepared
by spin-coating PEA (2.5%) solutions in toluene on Ti discs for 30 s at
2000 rpm. Before use, samples were oven-dried at 60 °C and vacuum
extracted.
2.2. Protein Coating. Protein coating of Ti discs was carried out
with 20 μg/mL ﬁbronectin isolated from human plasma (R&D
Systems Europe Ltd.). For atomic force microscopy (AFM) assays, the
coating was performed for a time of 10 min; then, samples were
washed once with PBS and three times with ultrapure water.19 For all
other experiments, titanium samples were UV-sterilized for 20 min and
coated with 20 μg/mL FN solution in DPBS (Gibco, Life
Technologies) for 1 h.7,19After that, the samples were washed with
DPBS and then coated with 25 ng/mL or 100 ng/mL BMP-7
solutions in DPBS (human recombinant BMP-7 cat. no. 354-BP, R&D
Systems Europe Ltd.) for 1 h. This was followed by a single wash with
DPBS; GF-negative samples were treated with DBPS. The volume of
coating solution and subsequent washes was 200 μL per sample in all
cases. After the coating, samples were preserved in DPBS until cell
seeding.
2.3. Characterization Tests. 2.3.1. Surface Wettability and
Homogeneity. Water contact angle (WCA) analysis was carried out
on Ti discs, glass discs, and on PEA-coated surfaces of both Ti and
glass discs using a THETA LITE optical tensiometer (Biolin Scientiﬁc,
Stockholm, Sweden) according to the method described previously.7
For each condition, static contact angle (SCA), advancing contact
angle (ACA), and receding contact angle (RCA) were determined.
Eight diﬀerent areas from two discs were analyzed for each angle value.
Contact angle hysteresis was interpreted as a measure of molecular
mobility for surfaces which are chemically homogeneous and ﬂat.7
Hysteresis values were calculated for each tested drop using ACA and
RCA measurements of that drop as a diﬀerence between ACA and
RCA.20
2.3.2. Atomic Force Microscopy (AFM). Ti discs coated with PEA
(Ti/PEA) and FN (Ti/PEA/FN) were prepared. These discs were
imaged using the AFM Nanowizard 3, JPK (Berlin, Germany). This
method was used to demonstrate the arrangement of FN adsorbed on
Ti surfaces. Three to six areas per sample were scanned (area size (1 ×
Figure 1. Characterization of engineered surfaces. (a) Scheme of a
biomimetic system consisting of Ti layer coated with PEA function-
alized with FN and speciﬁcally bound BMP-7 allowing synergistic
signaling. (b) Thickness of polymer layer on Ti in comparison with
glass tested by scratch assay; *** P < 0.001 (unpaired t test was used).
(c) Static water contact angle and hysteresis of bare Ti surface and Ti/
PEA, in comparison with glass surfaces; * P < 0.05; *** P < 0.001
(one-way ANOVA with Tukey’s post-test was used). (d) AFM images
of FN network on Ti/PEA surfaces. (e) BMP-7 bound to Ti, Ti/PEA,
and Ti/PEA/FN at two BMP-7 concentrations; the total amount of
BMP-7 bound per cm2 is shown; ns = nonsigniﬁcant; *** P < 0.001
(one-way ANOVA with Tukey’s post-test was used). (f) Cumulative
BMP-7 release from materials over 2 weeks; results shown as
percentage from the BMP-7 amount originally bound after 1 h of
coating. Asterisk labels above the bar without any linking lines to other
bars means this condition was signiﬁcantly diﬀerent from all other
conditions in the graph with the same level of signiﬁcance.
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1) μm2) with a line rate 1.0 Hz. The surface lock-in phase was
observed in tapping-mode using a cantilever with a force constant of 3
N/m and a resonance frequency of 75 kHz (MPP-21120, Bruker,
Billerica, MA).7 AFM imaging of uncoated Ti disc was performed
using a cantilever with a force constant of 40 N/m and a resonance
frequency of 300 kHz (DD-ACTA from AppNano). The AFM
measured height images of Ti alone discs were then utilized as an
indication of surface roughness. Nine scanned images with diﬀerent
scan areas (1 × 1 to 30 × 30 μm) were included. The proﬁle average
roughness values (Ra) and the root-mean-square roughness values (Rq)
were calculated by the manufacturer software (JPK Data Processing).
AFM was also used for measuring the thickness of the deposited Ti
and PEA layers: Ti and Ti/PEA discs were scratched to expose the
underlying glass layer of the coverslip using a sharp razor (3 parallel
scratch lines per disc in 2 replicates), height proﬁles were recorded
across the scratch lines, and thicknesses of Ti and PEA layers were
calculated.
2.3.3. BMP-7 Adsorption and Release. The amounts of BMP-7
bound to Ti, Ti/PEA, and TI/PEA/FN surfaces were quantiﬁed by
indirect enzyme-linked immunosorbent assay (ELISA) using DuoSet
human BMP-7 kit (R&D Systems, Minneapolis, MN).7 After the
samples were coated with BMP-7, the coating solutions and the ﬁrst
wash solutions were collected for analysis. The amount of BMP-7
bound to the samples was calculated as a diﬀerence between the total
BMP-7 used for coating and the amount of BMP-7 in the collected
solution. Two concentrations of BMP-7, 25 ng/mL and 100 ng/mL,
were used for the initial coating; all samples were in triplicates.
Cumulative BMP-7 release from all three tested surfaces was studied
over 2-week period after initial coating with 25 ng/mL BMP-7
solution; samples were incubated at 37 °C and 5% of CO2 covered
with 200 μL of DPBS; solutions were collected on the day 1, 2 and
then every second day, and the amount of BMP-7 released was
assessed using the same sandwich ELISA as for the BMP-7 adsorption.
2.4. Cell Cultures. Human mesenchymal stem cells (hMSCs) were
obtained from Promocell (cat. no. C-12975); cells were expanded in
high-glucose DMEM (Invitrogen) supplemented with 1.0% penicillin/
streptomycin and 5% FBS. Cells were passaged not more than 5 times
throughout the experiments. Cells were cultured at 37 °C, 5% of CO2,
and 100% humidity in a HeraCell incubator.
2.4.1. hMSCs Proliferation and Mineralization. For the prolifer-
ation assay, cells were seeded on Ti, Ti/BMP-7, Ti/PEA/FN, and Ti/
PEA/FN/BMP-7 surfaces (25 ng/mL of BMP-7 was used for the GF
coating where applicable). Seeding was done in serum-free medium
(high-glucose DMEM supplemented with 1.0% penicillin/streptomy-
cin) in 24-well plates at 10 000 cells/well (4 replicates per each time
point, day 1 and day 28 from seeding). After 2.5 h, the media were
changed to low serum growth medium (high-glucose DMEM
supplemented with 1.0% penicillin streptomycin and 5.0% FBS).15
Subsequently, the media were regularly changed every 2 days. An
additional set of 4 samples with cells on Ti surface was kept in
osteogenic medium (high-glucose DMEM supplemented with 10%
FBS, 10−7 M dexamethasone, 25 μg/mL L-ascorbic acid, and 3 mM
NaH2PO4), with the medium regularly changed. Cell proliferation was
assessed by using alamarBlue cell viability assay (Invitrogen).21 Prior
the assay, samples were transferred into a new 24-well plate and a fresh
low serum nonosteogenic medium was added to all wells. alamarBlue
reagent was then added at 50 μL/well followed by incubation for
exactly 2.5 h at 37 °C. Afterward, 100 μL was transferred from each
well into a black 96-well plate (Greiner Bio-One), and ﬂuorescence
was measured immediately at 590 nm (with excitation at 560 nm)
(Inﬁnite M200 PRO plate reader, Tecan Group Ltd.). The media were
then aspirated from the 24-well plate, and cells were washed twice with
DBPS without calcium and magnesium (Gibco).
Matrix mineralization was determined by a direct assay of total
calcium produced by the seeded cells under the same conditions as for
the proliferation assay. Calcium amount was analyzed by complexing
o-cresolphthalein complexone (Sigma-Aldrich, Fluka Analytical), 8-
Hydroxyquinoline (Sigma-Aldrich) and alkaline buﬀer reagent (Sigma-
Aldrich), according to reported methods.22 A standard calibration
curve was established to detect dilutions of 0−1600 μg/mL CaCl2·
6H2O (Sigma-Aldrich).
22 Measurements of calcium were performed
according to the following protocol: 500 μL of 1 M HCl was added
per well to lyse the cells. The plate was sealed and left on a rocker at
100 rpm for 8 h at room temperature to complete the lysation process.
Samples were then collected, and the o-cresolphthalein complexone
protocol was applied to obtain the calcium absorbance values which
were then converted according to the CaCl2·6H2O standard curve.
22
Another standard calibration curve relating known seeding counts of
hMSCs to the corresponding measured ﬂuorescence (at excitation 560
nm/emission 590 nm) was developed to interpret alamarBlue
ﬂuorescence readings.21 Calcium production results were then
normalized to the obtained viable cell count for each disc and
converted from CaCl2·6H2O to Ca
2+ equivalents and expressed in
picograms (pg) per viable cell.
2.4.2. Cell Viability. A LIVE/DEAD Viability/Cytotoxicity Kit “for
mammalian cells” (Molecular Probes) and NucBlue Live ReadyProbes
Reagent (Molecular Probes) were used to assess cell viability.23
Passage 1 hMSCs were seeded in 24-well plates for visualizing live and
dead cells on the discs after 1 and 28 days of cell culture. The tested
surfaces were seeded at 10 000 cells/disc in duplicates for day 1 and in
4 replicates for day 28. The medium and the seeding procedure were
identical to the alamarBlue assay; media were changed every 2 days. At
each time point (day 1 and day 28), a staining solution was made by
adding 8 μL of ethidium homodimer-1 and 2 μL of calcein AM to 90
μL of DPBS (Sigma-Aldrich), and 10 μL of the staining solution per
well was added, supplemented by 15 μL of NucBlue solution (without
removing the media). Samples were incubated 15 min at 37 °C, and
then the discs were ﬂipped inside the wells and directly imaged by
ﬂuorescent microscope (ZEISS AxioObserver.Z1).
2.4.3. Immunoﬂuorescence Staining. For focal adhesions, hMSCs
were seeded in a 24-well plate at a cell density of 3500 cells/cm2 onto
following surfaces: Ti/PEA/FN/BMP-7, Ti/PEA/FN, Ti/BMP-7, and
Ti only; samples were incubated for 24 h, then washed with PBS, ﬁxed
with 4.0% formaldehyde, permeabilized and stained for vinculin using
mouse monoclonal antivinculin antibody (Sigma-Aldrich) (1:400
dilution) detected by Cy3-conjugated Aﬃnipure rabbit antimouse
IgG (Jackson ImmunoResearch Laboratories Inc., West Grove, PA)
(1:200 dilution). Antibodies were diluted in 1.0% BSA (Sigma-
Aldrich) in PBS. Cytoskeleton was stained with BODIPY FL
Phallacidin (Molecular Probes) (1:100 dilution in PBS), and samples
were mounted with Vectashield with DAPI (Vector Laboratories).
A ﬂuorescent microscope ZEISS AxioObserver.Z1 was used for
imaging. Focal Adhesion Analysis Server (http://faas.bme.unc.edu/)24
was used for focal adhesion analysis of individual cells, and RStudio
software (Version 0.98.1102, RStudio, Inc.) and “R script” (by
Vanterpool and Gurden) were used to process the data obtained from
the server.
For late osteogenic markers staining, hMSCs were seeded at passage
2 into four well plates; two for osteocalcin (day 1 and day 28) and two
for osteopontin (day 1 and day 28). Four sample conditions were
included (Ti/PEA/FN/BMP-7, Ti/PEA/FN, Ti/BMP-7, and Ti
only), and the seeding density, cell culture steps, and culture medium
were identical to alamarBlue. The design incorporated duplicates for
day 1 and 4 replicates for day 28 in each group of surfaces. The media
were changed every 2 days until the time of analysis. At each time
point, the discs in the corresponding well plates were washed, ﬁxed,
and stained for osteopontin (1:50 dilution) and osteocalcin (1:50
dilution) (SantaCruz Biotechnologies).25 A 1:500 dilution of rhod-
amine phalloidin mixed with the secondary biotinylated antibody
solution was prepared, and applied to the sample discs. After washing
and mounting with Vectashield with DAPI, images were taken using
three channels of a ﬂuorescent microscope (osteocalcin or osteopontin
(green), actin (red), and DNA (blue)). Image analysis and
quantiﬁcation of osteocalcin and osteopontin staining and number
of nuclei was done using ImageJ software (Wayne Rasband, National
institutes of Health, Bethesda, MD, version 1.49P).
2.5. Statistical Analysis. All experimental results were interpo-
lated and analyzed using Microsoft Excel 2010 and GraphPad Prism
(GraphPad Software Inc.). Means and standard deviations were
calculated, and data were analyzed by t test, one-way analysis of
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variance (ANOVA) test with Tukey’s multiple comparison post-test,
or two-way ANOVA test with Bonferroni post-test where applicable
(mentioned in the text).
3. RESULTS
3.1. Characterization of Engineered Microenviron-
ments. Titanium samples were spin-coated with PEA solution
resulting in a PEA layer attached to Ti surface through physical
interaction after solvent evaporation. Their characterization was
done by testing the thickness of PEA coating (Figure 1b), and
surface wettability and molecular mobility. Figure 1c shows that
Ti coated with PEA has higher hydrophobicity in comparison
with the bare Ti surface.
Diﬀerences in the surface molecular mobility (homogeneity)
were reﬂected in the hysteresis results (Figure 1c). Uncoated Ti
surfaces (hysteresis ≈ 59.92°) were signiﬁcantly more
homogeneous than PEA-coated ones (hysteresis ≈ 68.23°)
(Figure 1c). The ability of PEA to induce FN assembly into
nanonetwork was assayed by AFM; Figure 1d shows FN
networks on Ti/PEA samples, while a scan of PEA-only-coated
Ti surface showed only a homogeneous signal (Supporting
Information (SI) Figure S1). The presence of FN network on
the Ti/PEA surface conﬁrmed observations from other studies
that FN conformation on PEA does not retain its globular
shape typical for nonspeciﬁcally bound FN or FN in solution.
FN network assembly occurs through physical adsorption on
PEA with no covalent bonding as described earlier,10 allowing
the encrypted domains for GFs and cell binding to be
exposed.11 The uncoated Ti metal surface AFM scan is also
shown (SI Figure S1). The mean average proﬁle roughness
values (Ra) was found to be 6.50 ± 0.56 nm, whereas the root-
mean-square roughness (Rq) was 8.25 ± 0.76 nm.
Binding of BMP-7 was studied using 25 ng/mL and 100 ng/
mL concentrations of BMP-7. At a lower BMP-7 concentration
in the coating solution, approximately 5 ng/cm2 of BMP-7
(more than 80% of the total protein) was bound to all sample
types (Ti, Ti/PEA, Ti/PEA/FN) (Figure 1e) with no
signiﬁcant diﬀerences found. Using a more concentrated
BMP-7 coating solution, the amount of approximately 15 ng/
cm2 of BMP-7 was bound to the surfaces, which represents
lower percentages in comparison with samples where 25 ng/
mL of BMP-7 was used for coating (SI Figure S2). However,
no signiﬁcant diﬀerences were found when comparing the
BMP-7 amounts bound to Ti, Ti/PEA, and Ti/PEA/FN discs
at the coating concentration that was used for all experiments
with cells (25 ng/mL) (Figure 1e). This is important as
diﬀerences in biological eﬀects between Ti only and Ti/PEA/
FN cannot be ascribed to diﬀerent amounts on BMP-7
adsorbed on these surfaces but rather to the level of speciﬁcity
of this binding, with FN networks enabling speciﬁc noncovalent
protein−protein interactions between BMP-7 and heparin-
binding domain of FN (FNIII12−14). This brings BMP-7 to
the close vicinity of the integrin-binding domain (FNIII9−10)
and allows enhanced synergistic signaling toward diﬀerentiation
after cell adhesion as it has been already described for BMP-2
and VEGF.11,12 We also monitored BMP-7 release from all
three types of surfaces over a 2-week period; in all conditions,
we observed minimal and stable release in time (Figure 1f).
From the day 4 until the end of the experiment, diﬀerent
conditions released signiﬁcantly diﬀerent amounts of BMP-7
when compared to each other with Ti surface releasing the
highest amount and TI/PEA the lowest. The diﬀerence
between Ti/PEA and TI/PEA/FN and thus diﬀerences in
cell behavior afterward cannot be ascribed to diﬀerent release
rates between both systems. Overall, we observed that BMP-7
binding was very strong on all surfaces as not more than 1% of
the BMP-7 bound to surfaces was released after 2 weeks.
3.2. Cell Adhesion. Analyses of focal adhesions (FA) and
cell area were performed 24 h after cell seeding. These assays
revealed that the size of hMSCs was similar on all surfaces
(about 5000 μm2, Figure 2a top). Measurements of total length
of focal adhesions showed that the total FA length was
signiﬁcantly higher for the bare Ti and Ti/BMP-7 in
comparison with samples coated with PEA (Figure 2a bottom).
There was no diﬀerence found between the median of FA
length neither for bare Ti and Ti/BMP-7 nor for Ti/PEA/FN
and Ti/PEA/FN/BMP-7. More detailed FA analysis (see SI
Figure S3 for details of image processing) showed that
distribution ratios for FA area (Figure 2b top) and distribution
ratios for FA axis length (Figure 2b bottom) correlate well. For
example, in the group of focal adhesions larger than 3 μm2 and
longer than 3 μm, there are more focal adhesions for Ti only
and Ti/BMP-7 samples, whereas in the group of the smallest
and shortest focal adhesions, there is higher prevalence of these
adhesions for Ti/PEA/FN and Ti/PEA/FN/BMP-7 samples.
Representative ﬂuorescence images showing vinculin present in
focal adhesions (Figure 2c) illustrate the results by showing
larger and longer focal adhesions on bare Ti surface and Ti/
BMP-7 in comparison with Ti/PEA/FN and Ti/PEA/FN/
BMP-7 substrates. Very large and more developed FAs on Ti
surfaces without PEA/FN coating suggest the cells are less
mobile on these substrates while more typical FA signature
Figure 2. Focal adhesion (FA) analysis in hMSC on material surfaces:
(a) Average cell size on Ti, Ti/PEA and with or without BMP-7
coating did not vary but signiﬁcant diﬀerences were found for FA
lengthTi with PEA coating had shorter FA than Ti alone or Ti/
BMP-7; * P < 0.05; *** P < 0.001 (one-way ANOVA with Tukey’s
post-test was used). (b) Distribution ratios for FA area and FA length.
(c) Representative images of ﬂuorescence labeled hMSC: Shorter FA
are present more often on PEA surfaces in comparison with Ti or Ti/
BMP-7 (inserts); vinculin representing FA is stained in red,
cytoskeleton in green, and nuclei in blue; scale bar is 20 um.
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found on Ti/PEA/FN and Ti/PEA/FN/BMP-7 surfaces
implies the cell ﬂexibility and higher potential for remodelling
and diﬀerentiation.
3.3. Growth and Diﬀerentiation of hMSCs. Total cell
numbers were quantiﬁed for day 1 and day 28 (Figure 3a). As
expected, there was no signiﬁcant diﬀerence between the
samples in number of cells 1 day after the seeding. After 28
days, the number of cells increased signiﬁcantly for Ti, Ti/
BMP-7, and Ti/PEA/FN samples, whereas for Ti/PEA/FN/
BMP-7 samples, it remained at the same level as on the day 1
this is expected if cells are diﬀerentiating rather than
proliferating. This result was supported by a lack of
proliferation on a diﬀerentiating control sample (cells seeded
on bare Ti and cultivated in osteogenic medium) on day 28
when compared with day 1. The decreased rate of cell
proliferation on Ti/PEA/FN/BMP-7 samples at the day 28 was
also conﬁrmed by additional cell number analysis based on
quantiﬁcation of nuclei on the tested surfaces (image analysis of
DAPI staining); the results including a comparison with
alamarBlue assay is shown in SI Figure S4. Live/Dead assay
at day 28 conﬁrmed that generally all cells found on surfaces
were alive (SI Figure S5 shows representative ﬂuorescence
images for this assay on day 28 and day 1).
Cell diﬀerentiation into osteogenic lineage was monitored by
measuring the level of calcium production, and also the
expression of osteogenic markers osteocalcin (OCN) and
osteopontin (OPN). Figure 3b shows normalized free calcium
production per viable cell for all tested surfaces and reveals the
system as the one with the highest calcium level and thus with
the best potential for osteogenic diﬀerentiation. Cells on the
three other systems produced generally less than a half of the
calcium amount than on Ti/PEA/FN/BMP-7 surface, and their
calcium level values were not signiﬁcantly diﬀerent among each
other. Osteogenic markers OCN and OPN were visualized in
hMSC by green immunoﬂuorescence after 28 days of cell
culture in growth medium (Figure 4a) and quantiﬁed by image
analysis. OCN production was signiﬁcantly higher for cells on
Ti/PEA/FN/BMP-7 surface when compared with cells on bare
Ti and on Ti/PEA/FN (Figure 4b top). OPN expression was
strongly enhanced in cells on Ti/PEA/FN/BMP-7 samples
(Figure 4b bottom); presence of OPN on the other three
surfaces was lower and did not vary signiﬁcantly among these
three conditions (Figure 4b bottom).
4. DISCUSSION
Titanium implants have shown long-term clinical success in
single and multiple restorations; however, they face the
disadvantage of prolonged osseointegration time.6,26 When
titanium was used in combination with BMP-7 in the medium
Figure 3. Cell proliferation and mineralization on Ti surfaces: (a) Cell
numbers on Ti/PEA/FN/BMP-7 are signiﬁcantly smaller in
comparison to three control surfaces (Ti alone, Ti/BMP-7, and Ti/
PEA/FN) after 28 days (dark bars), corresponding to the diﬀer-
entiation process rather than cell proliferation; a positive diﬀer-
entiation control with hMSC growing on Ti surface in the presence of
osteogenic medium (Ti + OM) also does not show any proliferation
after 28 days; * P < 0.05; ** P < 0.01; *** P < 0.001 (two-way
ANOVA with Bonferroni post-test was used). (b) Free calcium
production assay at day 28 showed higher amount of Ca2+ in hMSC on
Ti surface with PEA/FN/BMP-7 coating (dark green bar) in
comparison with other samples in growth medium, suggesting this
system to have the best potential for mineralization; diﬀerences
between other samples in growth medium were not signiﬁcant; *** P
< 0.001 (one way ANOVA with Tukey’s post-test was done). An
asterisk label above the bar without any linking lines to other bars
means this condition was signiﬁcantly diﬀerent from all other
conditions in the graph with the same level of signiﬁcance.
Figure 4. Osteogenic diﬀerentiation of hMSC on engineered surfaces after 28 days of culture: (a) Fluorescence images of hMSC with osteogenic
markers osteocalcin (OCN, top), and osteopontin (OPN, bottom) on Ti-functionalized substrate (Ti/PEA/FN/BMP-7) and three control surfaces;
OCN and OPN are stained in green, cytoskeleton is in red and DAPI in blue. Scale bar represents 100 μm. (b) Quantiﬁcation of OCN and OPN
staining showing a signiﬁcant increase in both markers on Ti/PEA samples functionalized with FN and BMP-7 (dark green bars); ** P < 0.01; *** P
< 0.001 (one-way ANOVA with Tukey’s post-test was done).
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to study osteogenic eﬀects in vitro, results were not uniform.
For example, one study showed no beneﬁt from the presence of
soluble BMP-7,27 while other works suggested increased
osteogenic potential in samples with BMP-7;28 however,
continuous supply of the growth factor was necessary. To
improve osteogenesis, while using low amounts of BMP-7, we
coated Ti samples with PEA that induces FN arrangement into
ﬁbrillar nanonetworks to allow speciﬁc binding of BMP-7 to
FN.7,10,29 Even though FN has been previously investigated as
coating material for dental implants, no signiﬁcant eﬀects has
been observed in vitro or in vivo.30−32Corresponding to the
important role of FN in ECM formation, FN nanonetworks on
PEA have shown to promote cell adhesion and diﬀerentiation
with diﬀerent cell types,7,10,29 and more importantly, enhanced
signaling via synergistic eﬀect between FNIII9−10 (integrin
binding region) and FNIII12−14 (GF binding domain) has
been described using BMP-2 and VEGF bound to FN on
PEA.11,12 In our Ti coatings, bound BMP-7 on assembled FN
nanonetworks on Ti/PEA activates growth factor receptors in
concert integrins after cell attachment to FN network, and
potentiates the response toward cell migration, proliferation
and diﬀerentiation.
Other strategies to present growth factors on material
surfaces include protein engineering techniques, the use of
peptides that bind GFs33 and the use of layer-by-layer
technologies.34,35 For BMP-7, systems such as BMP-7-loaded
PLGA nanocapsules in PCL scaﬀolds,36 BMP-7-adsorbed
deproteinized bovine bone,37 BMP-7 loaded PLGA micro-
spheres,38 microspheres from heparin-BMP-7 nanocomplex
entrapped in polyester matrix,39 or cells producing BMP-7
through lentiviral transfection40 have been developed so far.
However, these matrices all entrap BMP-7 nonspeciﬁcally, and
then relatively high concentrations of the growth factor had to
be used to achieve a biological eﬀect. These strategies are in
general more eﬀective than the soluble administration of
growth factors but, critically, do not exploit synergy between
growth factor and integrin receptors to accelerate healing.41
The potential importance of crosstalk between integrins and
growth factors was revealed in biological sciences more than a
decade ago,42 and was explicitly engineered into a ﬁbrin matrix
using a recombinant fragment of FN consisting of FNIII9−10/
12−14 that promoted bone regeneration and wound healing.43
We have engineered the cellular microenvironment to target
integrins and GF receptors synergistically with facile and
translatable materials technology using a simple coating of PEA
on Ti. Our system allows using much lower BMP-7 doses as it
utilizes its unique property to display the bound GF eﬃciently
next to the integrin binding domain and thus facilitates
enhanced cellular signaling.
Because in this study FN is used for its speciﬁc conformation
and ability to bind GFs prior cell attachment, for the ﬁnal eﬀect
it is crucial to have FN adsorbed prior implantation.
Nevertheless, we cannot exclude the role of interaction of
PEA and FN that is naturally secreted by cells. Indeed, in our
recent work we observed that although implantation of PEA
coated with FN without BMP-2 did not bridge a critical size
defect, it still provided higher levels of bone growth.11 We can
speculate that cellular FN follows the cues given by PEA;
however, considering the presence of other proteins, we do not
expect the complete FN network would be formed.44
It has been reported that BMP-7 has the potential to alter the
diﬀerentiation pathway in some cell types by hindering cell
cycle progression during early cell diﬀerentiation.44 Our results
corroborate these observations when presented from PEA
surfaces, with the proliferation rate being reduced with the
onset of diﬀerentiation.45 However, it has been reported that
the proliferative eﬀect of BMP-7 highly depends on the cell
type and culture conditions. In several reports, it has been
shown that hMSCs are nonresponsive to the induction of
cellular proliferation upon BMP-7 supplementation, having a
low level of mitogenic activity on these cells.8,15,45 Thus, our
results are highly consistent with these reports, which conﬁrms
the osteogenic potential of BMP-7 presented from a solid phase
on PEA at low concentrations.15,45
The mineralization of the bone adjacent to the implant
surface is a crucial process in the stability of osseointegrated
implants.26 Here, a direct assay of total calcium produced by
the cells was applied.22,46 It has been reported that metal ions
from the Ti surface potentially inhibit formation of
hydroxyapatite crystals on CP Ti or Ti6Al4 V surfaces in
vivo.26 This could explain low levels of calcium production after
28 days for bare Ti surface and Ti/BMP-7. From our results, it
is clear that the low concentration of BMP-7 used here is not
high enough to trigger osteogenesis on bare Ti, and about 10
times higher dose continuously supplied in the medium is
needed as reported before8,15 while the same low BMP-7
amount (25 ng/mL in a single coating) was suﬃcient for
reaching both higher calcium levels and signiﬁcant osteogenic
diﬀerentiation when presented on our Ti/PEA/FN/BMP7
system. Therefore, BMP-7 bound to PEA/FN is able to
promote cell diﬀerentiation using ultralow dose of BMP-7, as it
reported previously for this polymer using BMP-2 and VEGF
due to the crosstalk between integrins and GF receptors.11,12
There is a whole range of markers that can be used for
assessment of the level of osteogenic diﬀerentiation in vitro
including an early marker Runx2, osteocalcin, osteonectin,
osteopontin or alkaline phosphatase assay.47 We are conﬁdent
that by selecting osteocalcin and osteopontin protein
expression together with calcium production assay, we can
clearly show the osteogenic potential of our Ti/PEA/FN/BMP-
7 system as an increase of these parameters represents well the
diﬀerentiation process progressing into later stages.
It is important to note that our results clearly showed that
cell diﬀerentiation is predominantly due to the presence of
PEA/FN/BMP7 instead of other properties exhibited by
titanium surface, such as wettability or surface elasticity.
Further work will be focused on the development of plasma
polymerization of PEA enabling deposition of controlled
thickness on the surface of complex 3D titanium implants
that would be the next step toward clinical translation. Another
translation-related question is linked to a potential foreign body
reaction (FBR). We hypothesize that considering bioinert
characteristics of titanium together with our previous in vivo
studies with PEA not showing any major inﬂammatory
response, FBR will be low. However, it remains to be assessed
in future in vivo experiments. Stability of the Ti/PEA interface
is also of an interest from a long-term perspective, particularly
to avoid delamination and facilitating adhesion of the newly
mineralized tissue. We expect that, in vivo, Ti/PEA/FN/BMP-7
will boost stem cells toward osteogenic diﬀerentiation but the
thin layer of PEA will be eventually remodelled and
metabolized by cells. For this, further long-term in vivo
experiments need to be performed.
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■ CONCLUSIONS
The proposed delivery system for BMP-7 consisting of titanium
surface coated with poly(ethyl acrylate) speciﬁcally adsorbs
ﬁbronectin exposing growth factor and integrin binding
domains on its network. This strategy allowed us to
functionalize these substrates with extremely low concen-
trations of BMP-7, and thus to create a microenvironment
promoting hMSC diﬀerentiation toward osteogenic lineage. In
vitro cellular experiments using hMSCs from bone marrow
demonstrated the biocompatibility of the system and its ability
to induce a better late osteogenic diﬀerentiation response in
these cells. After 28 days of cell culture, the system induced the
highest level of matrix mineralization of hMSCs compared to
the control groups with identical cell culture media. This
technology opens up the way to use very low locally delivered
doses of BMP-7 to maximize osseointegration and thus increase
implants safety.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acsbiomater-
ials.7b01037.
AFM images of Ti surfaces, a scheme of focal adhesion
analysis process, and ﬂuorescence images of Live/Dead
assay (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: Manuel.Salmeron-Sanchez@glasgow.ac.uk.
ORCID
Vladimíra Moulisova:́ 0000-0003-0700-2837
Matthew J. Dalby: https://orcid.org/0000-0002-0528-3359
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